Sophia Adamia

2.9k total citations
69 papers, 1.5k citations indexed

About

Sophia Adamia is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Sophia Adamia has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 35 papers in Hematology and 23 papers in Genetics. Recurrent topics in Sophia Adamia's work include Chronic Lymphocytic Leukemia Research (22 papers), Acute Myeloid Leukemia Research (15 papers) and Multiple Myeloma Research and Treatments (14 papers). Sophia Adamia is often cited by papers focused on Chronic Lymphocytic Leukemia Research (22 papers), Acute Myeloid Leukemia Research (15 papers) and Multiple Myeloma Research and Treatments (14 papers). Sophia Adamia collaborates with scholars based in United States, Canada and France. Sophia Adamia's co-authors include Linda M. Pilarski, Christopher A. Maxwell, Patrick M. Pilarski, Andrew R. Belch, C. Backhouse, Fernando Gálvez, Greg G. Goss, Tony Reiman, James D. Griffin and Mary Crainie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sophia Adamia

68 papers receiving 1.4k citations

Peers

Sophia Adamia

HEMAT

GENET

ONCOL

Nuria Mencia-Trinchant United States

Christie Ciarlo United States

Anna Kalota United States

Kevin Rouault‐Pierre United Kingdom

Jason S. Damiano United States

Alice M.S. Cheung Singapore

Yen Phung United States

Giorgia Simonetti Italy

L M Pilarski Canada

Haiyan Xing China

Nuria Mencia-Trinchant United States

Sophia Adamia

579 ×0.8

468 ×1.0

HEMAT

209 ×0.7

GENET

163 ×0.6

222 ×0.9

ONCOL

Citations per year, relative to Sophia Adamia Sophia Adamia (= 1×) peers Nuria Mencia-Trinchant

Countries citing papers authored by Sophia Adamia

Since Specialization

Citations

This map shows the geographic impact of Sophia Adamia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophia Adamia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophia Adamia more than expected).

Fields of papers citing papers by Sophia Adamia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophia Adamia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophia Adamia. The network helps show where Sophia Adamia may publish in the future.

Co-authorship network of co-authors of Sophia Adamia

This figure shows the co-authorship network connecting the top 25 collaborators of Sophia Adamia. A scholar is included among the top collaborators of Sophia Adamia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophia Adamia. Sophia Adamia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adamia, Sophia, et al.. (2025). Evaluating the Diagnostic Potential of Biomarker Panels in Breast Cancer and Prostate Adenocarcinoma. Health Science Reports. 8(5). e70796–e70796.

Chyra, Zuzana, Sigitas Verselis, Ivane Abiatari, et al.. (2023). Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood Cancer Journal. 13(1). 23–23. 3 indexed citations

Weisberg, Ellen, Chengcheng Meng, Abigail E. Case, et al.. (2020). Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 24(5). 2968–2980. 19 indexed citations

Weisberg, Ellen, Chengcheng Meng, Abigail E. Case, et al.. (2020). Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia. Leukemia. 34(9). 2543–2543. 1 indexed citations

Adamia, Sophia, Ivane Abiatari, Samirkumar B. Amin, et al.. (2019). The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma. Leukemia. 34(1). 167–179. 9 indexed citations

Ögmundsdóttir, Helga M., Hlíf Steingrímsdóttir, Vilhelmína Haraldsdóttir, et al.. (2014). Inherited Polymorphisms in Hyaluronan Synthase 1 Predict Risk of Systemic B-Cell Malignancies but Not of Breast Cancer. PLoS ONE. 9(6). e100691–e100691. 4 indexed citations

Adamia, Sophia, Benjamin Haibe‐Kains, Patrick M. Pilarski, et al.. (2013). A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets. Clinical Cancer Research. 20(5). 1135–1145. 79 indexed citations

Adamia, Sophia, Patrick M. Pilarski, Andrew R. Belch, & Linda M. Pilarski. (2013). Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets. Current Cancer Drug Targets. 13(4). 347–361. 24 indexed citations

Jakubı́ková, Jana, Sophia Adamia, Maria Kost‐Alimova, et al.. (2011). Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood. 117(17). 4409–4419. 122 indexed citations

10.

Weisberg, Ellen, Arghya Ray, Erik A. Nelson, et al.. (2011). Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells. PLoS ONE. 6(9). e25351–e25351. 38 indexed citations

11.

Amin, Samirkumar B., Parantu K. Shah, Aimin Yan, et al.. (2011). The dChip survival analysis module for microarray data. BMC Bioinformatics. 12(1). 72–72. 8 indexed citations

12.

Weisberg, Ellen, Hwan Geun Choi, Rosemary Barrett, et al.. (2010). Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors. Molecular Cancer Therapeutics. 9(9). 2468–2477. 12 indexed citations

13.

Leleu, Xavier, Zachary R. Hunter, Lian Xu, et al.. (2009). Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia. British Journal of Haematology. 145(1). 59–63. 13 indexed citations

14.

Weisberg, Ellen, Renee D. Wright, Douglas W. McMillin, et al.. (2008). Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Molecular Cancer Therapeutics. 7(5). 1121–1129. 60 indexed citations

15.

Hunter, Zachary R., Leukothea Ioakimidis, Jacob D. Soumerai, et al.. (2008). Increased prevalence of monoclonal gammopathy, abnormal immunoglobulin levels, and recurrent infections in family members of patients with familial Waldenstrom’s macroglobulinemia. Journal of Clinical Oncology. 26(15_suppl). 8540–8540. 1 indexed citations

16.

Kaigala, Govind V., Jana Lauzon, Alexey Atrazhev, et al.. (2007). Microfluidic Chips for Detecting the t(4;14) Translocation and Monitoring Disease during Treatment Using Reverse Transcriptase-Polymerase Chain Reaction Analysis of IgH-MMSET Hybrid Transcripts. Journal of Molecular Diagnostics. 9(3). 358–367. 20 indexed citations

17.

Pilarski, Patrick M., Sophia Adamia, & C. Backhouse. (2005). An adaptable microvalving system for on-chip polymerase chain reactions. Journal of Immunological Methods. 305(1). 48–58. 26 indexed citations

18.

Adamia, Sophia, Steven P. Treon, Tony Reiman, et al.. (2005). Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenström's Macroglobulinemia. Clinical Lymphoma. 5(4). 253–256. 9 indexed citations

19.

Adamia, Sophia, Christopher A. Maxwell, & Linda M. Pilarski. (2005). Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer. PubMed. 5(1). 3–14. 130 indexed citations

20.

Adamia, Sophia, Mary Crainie, Jitra Kriangkum, et al.. (2003). Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia. Seminars in Oncology. 30(2). 165–168. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact